Baudax Bio acquires biotechnology firm TeraImmune

Baudax Bio has acquired all outstanding equity interests of biotechnology firm TeraImmune in a stock-for-stock deal.

Jul 3, 2023 - 20:00

Baudax Bio acquires biotechnology firm TeraImmune

Baudax Bio has acquired all outstanding equity interests of biotechnology firm TeraImmune in a stock-for-stock deal.

Read the original article

Tags:

Previous Article

Camena bags $10m in funding from Mercia

Generative AI – beyond the hype

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Almirall completes EU regulatory procedure for antifungal Jublia

Almirall completes EU regulatory procedure for antifung...

Oct 16, 2024

AHA 2024: Tirzepatide improves outcomes for major heart failure with HFpEF and obesity in SUMMIT

AHA 2024: Tirzepatide improves outcomes for major heart...

Nov 19, 2024

Streamlining healthcare with AI for drug development

Streamlining healthcare with AI for drug development

Jun 15, 2023